Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Hayes

Showing results (91-100 of 131) with videos related to

Pageof 14
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivorsV Stearns, C Isaacs, J Rowland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumorsJ Marshall, H Chen, D Yang, et al.
The New England Journal of Medicine|May 23, 1996
The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancerA Recht, S E Come, I C Henderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patientsC L Shapiro, P H Hardenbergh, R Gelman, et al.
Cancer|September 15, 1987
Primary radiation therapy for locally advanced breast cancerT Sheldon, D F Hayes, B Cady, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1994
Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancerA J Nixon, D Neuberg, D F Hayes, et al.
Breast Cancer Research and Treatment|July 19, 2017
Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcomeP Miller, K M Kidwell, D Thomas, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancerK A Havlin, M J Ramirez, C M Legler, et al.
Cancer|May 1, 1990
Adjuvant systemic therapy for patients with node-negative tumorsI C Henderson, D F Hayes, L M Parker, et al.
Cancer Research|April 6, 2001
Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B studyR A Bok, S Halabi, D T Fei, et al.
Pageof 14

Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivorsV Stearns, C Isaacs, J Rowland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumorsJ Marshall, H Chen, D Yang, et al.
The New England Journal of Medicine|May 23, 1996
The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancerA Recht, S E Come, I C Henderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patientsC L Shapiro, P H Hardenbergh, R Gelman, et al.
Cancer|September 15, 1987
Primary radiation therapy for locally advanced breast cancerT Sheldon, D F Hayes, B Cady, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1994
Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancerA J Nixon, D Neuberg, D F Hayes, et al.
Breast Cancer Research and Treatment|July 19, 2017
Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcomeP Miller, K M Kidwell, D Thomas, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancerK A Havlin, M J Ramirez, C M Legler, et al.
Cancer|May 1, 1990
Adjuvant systemic therapy for patients with node-negative tumorsI C Henderson, D F Hayes, L M Parker, et al.
Cancer Research|April 6, 2001
Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B studyR A Bok, S Halabi, D T Fei, et al.
Pageof 14